Tech Company Financing Transactions
Grail Funding Round
Grail, based in Menlo Park, secured $390 million in investment from Canada Pension Plan Investment Board, Illumina Ventures and PSP Investments.
Transaction Overview
Company Name
Announced On
5/15/2020
Transaction Type
Venture Equity
Amount
$390,000,000
Round
Series D
Proceeds Purpose
The Series D funding will support continued development and commercialization of GRAIL's multi-cancer early detection blood test.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
1525 O'Brien Dr.
Menlo Park, CA 94025
USA
Menlo Park, CA 94025
USA
Phone
Website
Email Address
Overview
Grail's mission is to detect cancer early, when it can be cured.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Hans Bishop
Chief Medical Officer
Joshua Ofman
Chief Operating Officer
Matthew Young
President
Harpal Kumar
VP - Bus. Development
Gautam Kollu
VP - General Counsel
Marissa Song
VP - R & D
Alex Aravanis
Browse more venture capital transactions:
Prev: 5/15/2020: Transect venture capital transaction
Next: 5/15/2020: Quizlet venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC transactions on this site are derived from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs